Systematic review of the Oxford Classification of IgA nephropathy: reproducibility and prognostic value

AJ Howie, AD Lalayiannis - Kidney360, 2023 - journals.lww.com
Background The Oxford classification of IgA nephropathy defined five prognostic features
scored subjectively in renal biopsies: mesangial cellularity (M), endocapillary …

Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis

J Lv, S Shi, D Xu, H Zhang, S Troyanov… - American Journal of …, 2013 - Elsevier
Background The Oxford Classification of the pathology of immunoglobulin A (IgA)
nephropathy, developed in 2009, is highly predictive of renal prognosis. It has been …

[HTML][HTML] Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group

H Trimarchi, J Barratt, DC Cattran, HT Cook, R Coppo… - Kidney international, 2017 - Elsevier
Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST
scores have been increasingly used in clinical practice. Further retrospective cohort studies …

[HTML][HTML] Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

R Coppo, S Troyanov, S Bellur, D Cattran, HT Cook… - Kidney international, 2014 - Elsevier
The Oxford Classification of IgA Nephropathy (IgAN) identified mesangial hypercellularity
(M), endocapillary proliferation (E), segmental glomerulosclerosis (S), and tubular …

Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy

CY Yoon, TI Chang, EW Kang, BJ Lim, JH Kie… - Annals of …, 2017 - Taylor & Francis
Abstract Background: The Oxford classification has been widely used in IgA nephropathy.
However, its clinical usefulness of determining immunosuppression is unknown. Aim …

The predictive value of Oxford MEST-C classification to immunosuppressive therapy of IgA nephropathy

YF Rui, ZJ Yang, ZH Zhai, C Zhao, L Tang - International Urology and …, 2022 - Springer
Purpose To analyze the efficacy of immunosuppressive therapy in IgA nephropathy and
investigate the value of all clinicopathologic indicators. Method One hundred and one …

Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors

T Moriyama, K Karasawa, Y Miyabe, K Akiyama… - Scientific reports, 2020 - nature.com
Abstract The Oxford classification for IgA nephropathy (IgAN) was updated in 2017. We have
validated the revised Oxford classification considering treatment with corticosteroids …

[HTML][HTML] The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

AWG of the International, IAN Network, DC Cattran… - Kidney international, 2009 - Elsevier
IgA nephropathy is the most common glomerular disease worldwide, yet there is no
international consensus for its pathological or clinical classification. Here a new …

Validating the oxford classification of IgA nephropathy

S Troyanov, FC Fervenza - … Journal of the American Society of …, 2011 - journals.lww.com
The evolution of patients with IgA nephropathy (IgAN) varies greatly, and predictive tools are
needed to assess confidently the risk for progression. Although in many studies clinical risk …

The Oxford classification of IgA nephropathy: a retrospective analysis

T Yau, SM Korbet, MM Schwartz… - American journal of …, 2011 - karger.com
Abstract Background/Aims: The Oxford classification of IgA nephropathy (IgAN) assesses the
presence of mesangial hypercellularity≧ 50%(M1 vs. 0), endocapillary proliferation (E1 vs …